Giorgio Sesti

Pubblicazioni

Titolo Pubblicato in Anno
Pharmacogenetics of oral antidiabetes drugs: Evidence for diverse signals at the IRS1 locus PHARMACOGENOMICS JOURNAL 2018
Branched-chain amino acid database integrated in MEDIPAD software as a tool for nutritional investigation of mediterranean populations NUTRIENTS 2018
One-hour post-load hyperglycemia: implications for prediction and prevention of type 2 diabetes THE JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 2018
Management of diabetes in older adults NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2018
Potential role of insulin receptor isoforms and IGF receptors in plaque instability of human and experimental atherosclerosis CARDIOVASCULAR DIABETOLOGY 2018
Use and effectiveness of dapagliflozin in routine clinical practice. An Italian multicenter retrospective study DIABETES, OBESITY AND METABOLISM 2018
Petition to replace current OGTT criteria for diagnosing prediabetes with the 1-hour post-load plasma glucose ≥ 155 mg/dl (8.6 mmol/l) DIABETES RESEARCH AND CLINICAL PRACTICE 2018
The place of gliclazide MR in the evolving type 2 diabetes landscape: a comparison with other sulfonylureas and newer oral antihyperglycemic agents DIABETES RESEARCH AND CLINICAL PRACTICE 2018
Competitive interaction between chronic obstructive pulmonary disease and CHA2DS2-VASc score in predicting incident atrial fibrillation INTERNATIONAL JOURNAL OF CARDIOLOGY 2018
Uric acid impairs insulin signaling by promoting Enpp1 binding to insulin receptor in human umbilical vein endothelial cells FRONTIERS IN ENDOCRINOLOGY 2018
Higher serum levels of uric acid are associated with a reduced insulin clearance in non-diabetic individuals ACTA DIABETOLOGICA 2018
The polymorphism rs35767 at IGF1 locus is associated with serum urate levels SCIENTIFIC REPORTS 2018
Serum IgG2 levels are specifically associated with whole-body insulin-mediated glucose disposal in non-diabetic offspring of type 2 diabetic individuals. a cross-sectional study SCIENTIFIC REPORTS 2018
Rationale and design of the DARWIN-T2D (DApagliflozin real world evIdeNce in Type 2 Diabetes). A multicenter retrospective nationwide Italian study and crowdsourcing opportunity NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2017
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial THE LANCET DIABETES & ENDOCRINOLOGY 2017
Hemorheological alterations in adults with prediabetes identified by hemoglobin A1c levels NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2017
A polymorphism at IGF1 locus is associated with anemia ONCOTARGET 2017
Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes. a meta-analysis of randomized controlled trials ACTA DIABETOLOGICA 2017
Mechanisms linking empagliflozin to cardiovascular and renal protection INTERNATIONAL JOURNAL OF CARDIOLOGY 2017
Elevated hemoglobin glycation index identify non-diabetic individuals at increased risk of kidney dysfunction ONCOTARGET 2017

ERC

  • LS4_9
  • LS4_10

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

- Meccanismi molecolari dell’azione insulinica e della funzione pancreatica;

- Fisiopatologia del diabete tipo 2 e dell’obesità;

- Genetica dell’insulino-resistenza, del diabete tipo 2 e dell’obesità;

- Sindrome metabolica e prediabete;

- Obesità metabolicamente sana;

- Trattamento del diabete tipo 2;

- Ruolo dell’IGF-1 nella patologia cardiovascolare e metabolica;

- Infiammazione, disfunzione endoteliale e patologia cardiovascolare;

- Epatopatie croniche e danno cardio-metabolico

Keywords

Diabetes Mellitus
obesity
cardiovascular disease

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma